Innovation Projects

The EIT Health Innovation Projects programme is a powerhouse for generating new ideas for healthcare.

Ideas supported for the EIT Health Innovation Projects are multidisciplinary and contribute to at least one of Europe’s diverse healthcare challenges. They include areas ranging from lifestyle interventions and nutrition, to brain health and treating chronic diseases, to social care and managing risk of exclusion, to improving healthcare systems.

Projects are categorised into one of two streams:

  • Innovation by Ideas: collaborative projects that are solution-driven and bottom-up;
  • Innovation by Design: collaborative projects that are needs-driven and start from a recognised market need or societal problem to deliver tangible results for citizens.

Do you prefer to watch the video in German, Spanish or French? Change the language by clicking on the little globe in the video.

Promoting this multidisciplinary approach to healthcare innovation will open doors to new collaborations, new products and services, and better care for citizens. This collaboration will be a key element in advancing innovation in European healthcare. As one of the world’s leading healthcare networks initiatives, EIT Health Innovation Projects is in a prime position to bring diverse ideas into the market.

EIT Health Germany supports German and Swiss partners and advises them in terms of project ideation and matchmaking to initiate relevant project collaboration at national and international level.

EIT Health Innovation Projects 2016 Video Innovation Projects Factsheets

Representation of German and Swiss partners in EIT Health Innovation Projects

German and Swiss Partners are represented in the following EIT Health Innovation Projects:

Innovation by Design

  • 2017

    ClassIDM – Integrated Care for Chronic Diseases

    Project leader: BD
    German / Swiss partners: Profil Institut für Stoffwechselforschung GmbH

    ClassIDM aims at establishing a test case demonstrating the clinical impact of a prototype Interconnected Diabetes Management (IDM) assistance system for improving metabolic control and life quality in patients with type 2 diabetes (T2D patients). ClassIDM will integrate functionalities enabling T2D patients to better manage their disease, with a strong behavioural approach, supported by a data collection and processing ecosystem, a data visualization platform and a Clinician portal.

    ClassIDM

    Individual Prostate Cancer Risk Score (STHLM3)

    Project leader: Karolinska Institutet, Thermo Fisher
    German / Swiss partners: Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Janssen-Cilag

    The aim of this project is to introduce, assess and refine a new application for individualised prostate cancer risk, the STHLM3 Risk Score. The STHLM3 Risk Score finds 20% more aggressive cancers and reduces the number of unnecessary biopsies with more than 50% compared to current clinical practice. The STHLM3 Risk Score was developed in a joint clinical research program between Thermo Fisher Scientific, a Swedish HCP and KI, combining genetic and protein biomarkers with clinical data in a multivariate algorithm.

    STHML3

  • 2016

    CLOSE

    Project leader: Profil Institut für Stoffwechselforschung GmbH
    German / Swiss partners: Roche Diagnostics GmbH, Institute for Applied Quality Improvement and Research in Health Care GmbH, European Research and Project Office GmbH

    CLOSE develops and deploys an integrated package centred on closed loop metabolic control for severely ill patients with Type 2 Diabetes. CLOSE will boost homecare service provision, improve quality of life of patients and their families and increase the sustainability of health care systems.

    CLOSE

    P3-Stroke

    Project leader: Siemens AG
    German / Swiss partners: Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen

    P3-Stroke will develop, implement and validate an integrated hybrid Angio-MRI system. This will improve the predictive prevention and personalised interventional stroke therapy, resulting in lower healthcare and socioeconomic costs and a unique selling proposition with new business opportunities.

    P3-Stroke

    PersoCo

    Project leader: Philips Electronics Nederland B.V.
    German / Swiss partners: Technische Universität München

    PersoCo will develop a digital cognitive assessment and intervention service for people experiencing cognitive decline. Users get insight into their cognitive functioning and are offered solutions for their daily life problems. Prolonged usage is stimulated by innovative personalised engagement techniques.

    PersoCo

    Vitality

    Project leader: Philips
    German / Swiss partners: Deutsches Zentrum für Diabetesforschung (DZD)

    Vitality integrates a self-management service, promoting healthy living to prevent the risk of diabetes and prevent worsening of diabetes, in the offerings and vitality platforms of insurance companies and service providers and will be endorsed by medical and non-medical professionals. The service includes lifestyle monitoring devices and a personalized coaching service focusing on daily life. The consortium consists of leading partners in the field.

    Vitality

Innovation by Ideas

  • 2017

    ComRAD – World’s first respiratory assist device

    Project leader: RWTH Aachen
    German / Swiss partners: Uniklinik Aachen

    ComRAD is the world’s first respiratory assist device specifically designed for long term treatment of patients with life threatening lung diseases. The device uses an innovative approach for heart-lung support by mimicking the elasticity of the native lungs. That makes the device more efficient with significantly lower associated risks while also allowing affected patients for the first time to be mobilized again.

    Comrad

    LUCINDA

    Project leader: Oxford University Hospitals NHS Trust
    German / Swiss partners: Universitätsklinikum Heidelberg

    Lung cancer is the most lethal cancer. Early detection by Computed Tomography (CT) significantly improves survival. Lung Virtual Biopsy enables earlier, more confident and cost-efficient lung cancer diagnosis, using the existing CT scanner available in almost every modern hospital, Machine Learning and vast database of CT scans.

    Lucinda

    Therapy Lens

    Project leader: Technische Universität München (TUM)
    German / Swiss partners: RWTH Aachen

    The Therapy Lens app will utilize the latest augmented reality technology in order to provide virtual support for patients with neurological diseases at home. Using the Microsoft HoloLens users will receive support from the app through holograms presented in their field of view. These holograms provide a foundation for the four main features of the app: a “virtual carer”, virtual support in complex tasks, rehabilitation games and an artificial intelligence companion.

    Therapy-Lens-1

  • 2016

    Active Hands

    Project leader: Technische Universität München

    The Active Hands project will develop an innovative home-based guidance system that will support individuals who have suffered functional loss in daily tasks such as tea making. The platform will track the movements made by a user during the task and provide tailored information about the correct next task action if an error is performed.

    The-Active-Hands-Project

    AVC (finished in 2016)

    Project leader: AbbVie Deutschland GmbH & Co. KG
    German / Swiss partners: Ruprecht-Karls-Universität Heidelberg

    AbbVie Cares improves work-related health, work-ability and productivity for people at AbbVie and beyond. The KAVA accelerates technology readiness and scalability with four components: a toolbox for monitoring health-related work-site interventions and three comprehensive educational suites.

    DeTecT2D

    Project leader: Deutsches Zentrum für Diabetesforschung e.V.
    German / Swiss partners: Technische Universität München, Universitätsklinikum Tübingen, Ludwig-Maximilians- Universität, Helmholtz Zentrum München

    The early detection of Type 2 diabetes (T2D) is essential to apply intervention strategies, enable healthy ageing and lessen the burden on healthcare systems. DeTecT2D aims to develop and commercialise a diagnostic assay to replace OGTT, and to train young researchers in translational implementation.

    Detect2D

    HandTech

    Project leader: ETH Zürich
    German / Swiss partners: Hocoma

    Cooperative hand movements are based on a neural coupling mechanism. After stroke the unaffected hemisphere becomes involved in movement performance of the paretic hand. This effect can be enhanced by a training of cooperative hand movements required during daily life activities with the consequence of an improved quality of life. A novel training device will allow such a training of cooperative hand movements.

    I4PCM

    Project leader: Institut de Cancérologie Gustave Roussy
    German / Swiss partners: Deutsches Krebsforschungszentrum, AbbVie Deutschland GmbH & Co. KG Roche Diagnostics GmbH, SAP

    I4PCM involves six EU centres to create a common data platform addressing current challenges in cancer medicine, leading the way for a virtual European Cancer Institute. The project will explore care and clinical research as well as identify patient responses to immunotherapy through biology, genomics, and imaging.

    I4PCM

    MACH

    Project leader: Rheinisch-Westfaelische Technische Hochschule Aachen
    German / Swiss partners: BerlinHeart GmbH

    Children in end-stage heart failure awaiting transplantation are hit harder by the shortage in donor organs than adults: Due to the lack of miniaturised heart assist devices, they are constantly “detained” in intensive care wards. The device developed will help children regain a greater degree of independence.

    MACH

Defining Innovations

  • A Product Innovation is a good or service that is new or significantly improved. This includes significant improvements in technical specifications, components and materials, software in the
    product, user friendliness or other functional characteristics.
  • A Process Innovation is a new or significantly improved production or delivery method. This includes significant changes in techniques, equipment and/or software.
  • A Marketing Innovation is a new marketing method involving significant changes in product design or packaging, product placement, product promotion or pricing.
  • An Organisational Innovation is a new organisational method in business practices, workplace organisation or external relations.

With EIT Health, we put the patient in our focus. We want really to improve the health and the life of the people, the patients in Europe.

Dr. Volker Lodwig
Chair of Supervisory Board of German EIT Health GmbH / Head of Public Policy, Roche Diagnostics GmbH

It is important for us to collaborate with other organisations and to meet new partners. For us it is a great opportunity also to explore new business areas.

Prof. Dr. Freimut Schliess
Director Science and Innovation, Profil Institut für Stoffwechselforschung GmbH

Back to top
Image of

Close